Test Code RISAP Risankizumab Quantitation with Antibodies, Serum
Additional Codes
Epic EAP: LAB11481
Epic Description: RISANKIZUMAB QUANT WITH ANTIBODIES, S
Specimen Required
Patient Preparation: For 12 hours before specimen collection, patient should not take multivitamins or dietary supplements (eg, hair, skin, and nail supplements) containing biotin (vitamin B7).
Supplies: Sarstedt Aliquot Tube, 5 mL (T914)
Container/Tube:
Preferred: Serum gel
Acceptable: Red top
Submission Container/Tube: Plastic vial
Specimen Volume: 1.5 mL
Collection Instructions:
1. Draw blood immediately before next scheduled dose (trough specimen).
2. Within 2 hours of collection, centrifuge, and aliquot serum into a plastic vial.
Secondary ID
621813Useful For
Evaluation of patients with limited primary (initial) response to or secondary loss of response to risankizumab
Profile Information
Test ID | Reporting Name | Available Separately | Always Performed |
---|---|---|---|
RISA | Risankizumab, S | Yes | Yes |
RISAB | Risankizumab Ab, S | No | Yes |
Testing Algorithm
For more information see Ulcerative Colitis and Crohn Disease Therapeutic Drug Monitoring Algorithm.
Special Instructions
Method Name
RISA: Liquid Chromatography Mass Spectrometry (LC-MS)
RISAB: Electrochemiluminescent-Bridging Immunoassay (ECLIA)
Reporting Name
Risankizumab QN with Antibodies, SSpecimen Type
SerumSpecimen Minimum Volume
0.75 mL
Specimen Stability Information
Specimen Type | Temperature | Time | Special Container |
---|---|---|---|
Serum | Refrigerated (preferred) | 28 days | |
Frozen | 28 days |
Reject Due To
Gross hemolysis | OK |
Gross lipemia | Reject |
Gross icterus | OK |
Heat-treated specimens | Reject |
Reference Values
RISANKIZUMAB QUANTITATION:
Risankizumab lower limit of quantitation =1.0 mcg/mL
RISANKIZUMAB ANTIBODIES:
Antibodies to risankizumab: <20.0 ng/mL
Day(s) Performed
Weekly
Report Available
2 to 9 daysPerforming Laboratory
Mayo Clinic Laboratories in RochesterTest Classification
This test was developed and its performance characteristics determined by Mayo Clinic in a manner consistent with CLIA requirements. It has not been cleared or approved by the US Food and Drug Administration.CPT Code Information
80299
82397
LOINC Code Information
Test ID | Test Order Name | Order LOINC Value |
---|---|---|
RISAP | Risankizumab QN with Antibodies, S | 105194-5 |
Result ID | Test Result Name | Result LOINC Value |
---|---|---|
621304 | Risankizumab, S | 105041-8 |
621769 | Risankizumab Ab, S | 105195-2 |
621812 | RISAB Interpretation | 59462-2 |
Forms
If not ordering electronically, complete, print, and send Gastroenterology and Hepatology Test Request (T728) with the specimen.